chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Inflammatory pain; Little dizziness/Light headedness; Fatigue; Arthritis pain in hip, in hand and in wrist; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received her first dose of bnt162b2 (BNT162B2 reported as Pfizer's COVID Vaccine; lot number: EL1284; expiration date: 30Apr2021), via an unspecified route of administration left upper arm on Jan2021 at a single dose for covid-19 immunization. Medical history included lupus. There were no concomitant medications. The patient reported that she got her first dose of the COVID Vaccine 2 weeks ago today (Jan2021), and this is her second dose next Saturday. She was a non-medicated, non-kind of remission level of lupus. She mentioned that she was okay the second day, she thinks. She had a little dizziness, fatigue and light headedness that kind of thing. But the top 3 or 4 days ago, so like on her 8th or 9th day, she started to get like inflammatory symptoms like arthritis pain in her hip, in her hand, in her wrist. It was also reported that the patient experienced inflammatory pain on an unspecified date. So, she was just wondering if there are any reports of people with lupus and if the other people have reported that. She mentioned that she wanted to get the second dose but was a little concerned if those arthritis symptoms are going to be worse. No treatment was received. The causality was reported as yes. The patient she hasn't gone visit any emergency room/ physician's office for the adverse events. The outcome of the events was unknown.
MA gave vaccines to pt; ask mother to stay for about 20 minutes for any reaction. After 10 minutes came back to room to check on pt. Mother told me he had developed some rash on face I called Dr to evaluate.
I WOKE UP NEXT DAY WITH A FEVER & BODY ACHES & CHILLS ON THE 4/28/2021 I WOKE UP AND DICOVERED A MASS UNDER MY RIGHT ARM SO I WENT TO MY OBGYN
9 month old male received IM immunization in R thigh on. Fever and vomiting night of immunization. T 103, swelling R thigh, and decrease use R leg on day of admission (6 d within immun.) PE-R thigh 6x6cm area induration and erythema, warm to touch. Improved ? still ? 3/12/03. R leg 2/5/03-significant SC edema R thigh. The 60 day follow up states clinically normal. Follow up ultrasound of R thigh-resolution of soft tissue mass by ultrasound (5/15/03).
Headache pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache pain) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 039B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache pain). The patient was treated with IBUPROFEN for Headache and Pain, at a dose of 800 mg. At the time of the report, HEADACHE (Headache pain) outcome was unknown.            Patient reported that she had taken Ibuprofen a couple of days before on 15-May-2021 for Menstrual cycle cramps. No other concomitant medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-138608 (Patient Link).
Headache, Facial swelling and itching onset n/aapprox 8 hours after injection
patient called to report a reaction which he thinks was attributed to his flu shot. about 30 minutes after, he experienced flushing and hot face. noticed quite red in the face. he thought he looked a little "blotchy" for a while. symptoms were subsiding, but he was planning to take a benadryl or two. pt reported getting flu shots many times in past with no rxn. he did get tested for an allergy to penicillin and the md said while he did not show a allergy to penicillin, he did seem to have an allergy to an "additive".
Pt developed fever, couldn't walk, shaking, epileptic seizure around 18:45 to 19:45. Tympanic temperature at 18:30 was 103.2F. Approx. 1 hour after removal of bandaid, the pt had a small seizure. Upon discharge, the pt still had a fever.
Extreme chills, full body aches, skin unbearably painful to touch clothes, edema of legs and neck, fatigue, shortness of breath, joint pain, can barely walk or move
Headaches for two days after shot.  One week after shot, extreme tiredness, headaches, severe sore throat.  Symptoms still persisting.
Blood clots in lungs; Unable to walk due to lack of oxygen; Unable to walk due to lack of oxygen; she has left heart damage; This serious case was reported by a consumer via call center representative and described the occurrence of pulmonary thrombosis in a elderly female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Concurrent medical conditions included atrial fibrillation.   On 01-SEP-2023, the patient received the 1st dose of Arexvy. On 04-SEP-2023, 3 days after receiving Arexvy, the patient experienced pulmonary thrombosis (Verbatim: Blood clots in lungs) (serious criteria hospitalization and GSK medically significant), hypoxia (Verbatim: Unable to walk due to lack of oxygen) (serious criteria hospitalization and GSK medically significant) and unable to walk (Verbatim: Unable to walk due to lack of oxygen) (serious criteria hospitalization). In SEP-2023, the patient experienced heart disorder (Verbatim: she has left heart damage) (serious criteria hospitalization).  The outcome of the pulmonary thrombosis, hypoxia and unable to walk were unknown and the outcome of the heart disorder was not reported.   It was unknown if the reporter considered the pulmonary thrombosis, hypoxia, unable to walk and heart disorder to be related to Arexvy.     It was unknown if the company considered the pulmonary thrombosis, hypoxia, unable to walk and heart disorder to be related to Arexvy.   Additional Information: GSK Receipt Date: 11-SEP-2022/ 14-SEP-2023 The reporter reported that the patient received Arexvy vaccine and experienced unable to walk due to lack of oxygen. The patient went to the emergency department then sent to the cath lab where they removed multiple clots from her lungs. The patient mentioned that she had left heart damage. The patient was in intensive care for 5 days. The patient stated that she was not warned not to take the vaccine due to her existing Atrial Fibrillation status and that she would not have taken the vaccine if she had been warned. The reporter reported that please do not contact until after patient sees the doctor on 19th September 2023. The reporter consented to follow up.
Experienced tiredness; Nausea; I was catching the flu; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Experienced tiredness"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; INFLUENZA (non-serious), outcome "unknown", described as "I was catching the flu".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a Medical Assistant refers to a multiple patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown date, the patient was vaccinated with GARDASIL lot#K006960 expiration date 19-FEB-2017 and lot#K005083 expiration date 04-NOV-2016 (dose was not reported). The patients received a dose of GARDASIL that was stored improperly. There was no adverse effects reported. Additional information has been requested.
12/7/2010 Onset of nausea, vomiting, sore throat, confusion & headache.  12/8/2010 Taken to ED with temp. of 102.7 & admitted to ICU with Dx Neisseria meningitidis septic shock & bacteremia.
Employee administered Fluzone "high dose" Quadrivalent Flu vaccine by 11-7 Supervisor. Employee under 65 years of age. Currently employee only reports erythema to left arm at injection site.
Initial misuse report received from a healthcare professional on 05 June 2013. A male patient was administered Tetanus Toxoid Ads vaccine (Lot number: U3989BA), while administering some leaked out at the injection site. No adverse event was reported. Documents held by sender: none.
Pt came to urgent care 01/23/04 for complaints of redness, swelling, warmth to left arm.  Received 4 year old vaccine (DTAP, IPV) left arm, MMR right arm 01/22/04.  No fever.  Benadryl 25mg per mouth given and then to be given every 6 hours.
Intense erythema, induration, tenderness and warmth on the lateral arm at the level of the bicep immediately below the injection site extending 4 inches above antecubital fossa.
numbness on the right side of my face, beginning by my right ear and slowly moving along my right jaw down to my chin then felt it all the way up along the right side of my nose to my eye. The numbness felt like when novocaine is wearing off after getting a tooth filled-i could feel and move my facial muscles and eat but the muscles felt weaker-my right nostril kept running, more saliva was produced on my right side and I had to constantly swallow and my right eye felt dry and sore. This started about 4-5 hours after receiving the vaccine and lasted only a few hours. By the next day, all sensations were gone just the predicted sore arm and slight achiness.
Red welt at injection site 8 days after receiving vaccine; It itched at first but now feels warm; It itched at first but now feels warm; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 04Mar2021 at 14:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fluticasone propionate (FLONASE) and azelastine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 12Mar2021, the patient experienced red welt at injection site 8 days after receiving vaccine. It itched at first but now feels warm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red welt at injection site 8 days after receiving vaccine. It itched at first but now feels warm was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Skin breakout all over body same month after shot. Circular regions with an indented middle all over body that itch very bad. This has continued for months since the shot all over my legs, arms, butt, stomach, back, scalp, back. Just all over my total body. I have never had this issue before in my life.
On 7/22/2009 right arm became swollen, red and warm and symptoms have progressed. Mom gave children's TYLENOL from 7/22/2009-7/24/2009. No fever. Temperature 99.1 (Tympanic).
Can not raise or move my left arm up and down, side to side from 9-18-09.
A few days after receiving the vaccine my blood pressure became elevated to 190. If I calmed down it got better. I felt like my heart rate raised a couple of times a day. The spikes in my blood pressure and heart rate lasted about four days. It felt a little like an anxiety attack. I was prescribed a Diuretic which  I took for a week. When you got the second dose I did not have any of the same symptoms.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medication were unknown. On 08-SEP-2016, the patient was inadvertently vaccinated with a dose of expired M-M-R II (dose and route unknown, lot# reported as M001200, expiration date: 28-AUG-2016). No adverse effect was reported. Additional information has been requested.
Report 2001021333-1 described rash in an eight month old female who received Infanrix. The vaccinee's allergies, medical history and concomitant medications were not specified. On an unspecified date, the vaccinee received her first dose of Infanrix. One week later, she experienced a raise, red, rash. As of 08/31/2001, the outcome of the event was unknown.
This spontaneous report as received from a physician refers to 10 patients of unknown age. On unknown dates the patients were vaccinated with quadrivalent human papillomavirus (types 6,11, 16,18) recomb. vaccine (manufacturer unknown). The reporter stated that only protect against the four certain strains of HPV vaccine. The reporter got the information from a performance enhancing drug (PED) article in essence magazine in 2011 (it was reported as three years ago). There was side effects involved in the article, which interviewed 10 families who had bipolar affective disorder (BAD) experienced. This is a deterrent against the reporter getting the medication. The outcome of the patients were unknown. The reporter considered the event to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown). Additional information has been requested.
Very sore arm and overall sore musculature throughout body starting the evening of the vaccine. Patient reported feeling very bad but didn't have a fever
Systemic: Dizziness/Lightheadedness-Mild, Systemic: Exhaustion/Lethargy-Mild, Systemic: Fainting/Unresponsive-Severe, Systemic: Headache-Mild, Additional Details: Patient fainted and was unresponsive for about 5 minutes. Her partner was with her and checking on her to try to have her respond. The pharmacist was at scene asking patient and partner if CPR assistance could be provided. 911 was called and ambulance arrived. Right before response team arrived patient was awake and responsive. She wanted to go home and not in the ambulance. Patient stated she had a needle phobia and chance of fainting after receiving vaccinations.
Two days after I started to have a pain in the middle of my chest.  It started fairly constant and now gets a little better each day.  Along with the pain in my chest, my face flushes often.
PATIENT HAD COVID IN DECEMBER 2020, HE WAS ADMITTED IN JANUARY FOR COVID PNEUMONIA AND HE DID RECEIVE MONOCLONAL ANTIBIODIES. HE RECIEVED HIS FIRST DOSE OF THE MODERNA VACCINE ON MAY 20,2021 ON MAY 21,2021 HE WAS UNABLE TO STAND, WALK OR SIT UP. HE WAS UNABLE TO EAT OR DRINK. HE DENIES FEVER, CHILLS, HEADACHE. THESE SYMPOTMS LASTED FOR 48 HOURS AND HE WILL NOT BE VACCINATED WITH HIS 2ND DOSE.
Pt recvd 3 doses of Engerix-B & was determined to be a non-responder by repeat testing; pt recvd a booster dose of Engerix-B on 20AUG91 & 25OCT91 c/o painful/burning sensation in hands; lyme test was neg; questionable arthralgia from vax;
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck. Follow up information has been received from the registered nurse who provided patients' details. This report refers to a 4 months old infant patient of unknown gender. On 20-JUN-2014, the patient was vaccinated with a dose of PEDVAXHIB lot number J016188, expiration date: 02-OCT-2016, (dose and route were not reported) that was improperly stored. No adverse effects reported. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Swollen, red left arm from shoulder to elbow.  Painful.  Revac done do to storage too cold within on 09/10/03.
Patient reports soreness in the right arm that radiates down arm. He states that it began right after vaccination and has not resolved yet. States that in last 10 days he has experienced slight pain and numbness in fingers of the same arm. He states he experiences significant pain when laying on shoulder and when applying downward pressure to lift himself. At the time he reported this to me (oct 27,2009) I recommended that he see his physician to evaluate his symptoms. He insisted that the vaccination was the source of his symptoms.  He has not reported back to me at this time.
6/13/13 Erythema multiforme x 7 days trunk and extremities. 8/29/13 Erythema multiforme x 7 days trunk and extremities.
Subsequent to receiving second dose of varicella virus vaccine live the pt experienced a pox like rash consisting of 3 lesions on her body and 5-6 lesions in her mouth.
Complaint of shortness of breath/difficulty breathing, cough, chills, elevated temperature up to 101.5, sore/scratchy throat, headache, runny nose/congestion, loss of taste and smell, myalgia,  and malaise
suffered a TIA, was taken to the local Hospital.   Suddenly I had tingling throughout my body, became dizzy and disoriented very quickly.   Lost speech and periferal vision.   Could not understand any voices from people surrounding me.
A little hot to touch at injection site; Rash at injection site; Pain in right side of hip; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at injection site), VACCINATION SITE WARMTH (A little hot to touch at injection site) and ARTHRALGIA (Pain in right side of hip) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ARTHRALGIA (Pain in right side of hip). On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at injection site). On an unknown date, the patient experienced VACCINATION SITE WARMTH (A little hot to touch at injection site). The patient was treated with PARACETAMOL (TYLENOL ACHES & STRAINS) at an unspecified dose and frequency. On 14-Jan-2021, ARTHRALGIA (Pain in right side of hip) had resolved. At the time of the report, VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE WARMTH (A little hot to touch at injection site) had not resolved.
Rashes (hives) all over her body x 2 wks after receiving the H1N1 (Novel) injection. Pt using anti-itching cream to relieve itchiness.
loose stool, vomiting, profuse sweating, weakness ( felt as though I would pass out) Lasted about a half hour
17 years of age patient received a Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age patient received a Moderna vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age patient received a Moderna vaccine). On 27-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years of age patient received a Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. No treatment information was provided.
Injection site pain; Tiredness; Headache; Muscle pain; severe muscle pain; Chills; Injection site swelling; Injection site redness; Feeling unwell; Swollen lymph nodes; my whole throat swelling; I can't get off the couch I'm in too much pain; Fever; the first shot in my leg; Left leg; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old patient received bnt162b2 (BNT162B2), administration date 18Aug2021 (Lot number: FC3181) at the age of 64 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Crohn's disease" (unspecified if ongoing). Concomitant medication(s) included: ENTYVIO taken for crohn's disease. The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 18Aug2021, outcome "unknown", described as "the first shot in my leg; Left leg"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Injection site pain"; FATIGUE (non-serious), outcome "unknown", described as "Tiredness"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; MYALGIA (non-serious), outcome "unknown", described as "Muscle pain; severe muscle pain"; CHILLS (non-serious), outcome "unknown", described as "Chills"; VACCINATION SITE SWELLING (non-serious), outcome "unknown", described as "Injection site swelling"; VACCINATION SITE ERYTHEMA (non-serious), outcome "unknown", described as "Injection site redness"; MALAISE (non-serious), outcome "unknown", described as "Feeling unwell"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Swollen lymph nodes"; PHARYNGEAL SWELLING (non-serious), outcome "unknown", described as "my whole throat swelling"; PAIN (non-serious), outcome "unknown", described as "I can't get off the couch I'm in too much pain"; PYREXIA (non-serious), outcome "unknown", described as "Fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vaccination site pain, fatigue, headache, myalgia, chills, vaccination site swelling, vaccination site erythema, malaise, lymphadenopathy, pharyngeal swelling, pain, pyrexia.  Additional Information: Patient got a severe reaction to this vaccine. Patient took Tylenol and ice packs and CBD with turmeric and inflamed and Benadryl. No any other vaccine administered within four weeks prior to administration of first COVID shot.  Follow-up attempts are completed. No further information is expected.
Generalized malaise, sore throat, rash on body starting 7 days after vaccines given.  Lasting 1 week +.